Novel PPAR-γ agonists as potential neuroprotective agents against Alzheimer's disease: rational design, synthesis evaluation, PPAR-γ binding assay and transactivation and expression studies.

Alzheimer's disease (AD) is a neurological disorder. It is caused by accumulation of amyloid beta (Aβ) plaques and tau tangles, which gradually leads to cognitive decline and memory loss. Peroxisome proliferator-activated receptor gamma (PPAR-γ), a nuclear receptor, plays a significant role in regulating genes responsible for metabolism and inflammation.

Ferromagnetic ZnO nanostructures from an organo zinc complex formulated via Piper Longum L-assisted green synthesis: Multifaceted prospects in photocatalysis, antimicrobial activity, and cell viability studies.

Transition metal oxides like ZnO nanostructures are pivotal in various scientific and technological fields due to their chemical stability, high electrochemical coupling efficiency, and broad radiation absorption spectrum. This study offers an in-depth examination of ZnO nanostructures synthesized via the green route using Piper Longum L, emphasizing their photocatalytic efficacy in degrading organic pollutants such as Sulphanilamide and Chromium. The ZnO nanostructures with a rod-like morphology exhibited an average crystallite size of 26 nm and an optical bandgap of 2.

Surrogate imaging markers of Urodynamic proven bladder dysfunction in posterior urethral valves: A comprehensive evaluation.

Introduction: Although urodynamic evaluation forms the cornerstone of diagnosis and management of bladder dysfunction in posterior urethral valves (PUV), yet it could be helpful to learn if there are any non-invasive surrogate imaging markers for the same.

Aim: To study the diagnostic accuracy of various imaging surrogate markers of urodynamic proven bladder dysfunction in PUV.

Method: This cross-sectional study over two years included 38 children of endoscopically proven PUV.

Virtual screening-based identification of novel fatty acid synthase inhibitor and evaluation of its antiproliferative activity in breast cancer cells.

Cancer cells activate de novo lipogenesis by overexpressing the lipogenic enzymes ACLY, ACC and FASN to support rapid cell division. FASN, previously known as oncogenic antigen-519 (OA-519) catalyzes seven sequential reactions to synthesize palmitic acid (C16) from substrates acetyl CoA, and malonyl CoA. The dependence of cancer cells on FASN-derived lipids and the differential expression of FASN in cancer cells compared to their normal counterparts make it an attractive metabolic drug target in cancer therapy.